Cargando…

A cardiovascular disease policy model that predicts life expectancy taking into account socioeconomic deprivation

OBJECTIVES: A policy model is a model that can evaluate the effectiveness and cost-effectiveness of interventions and inform policy decisions. In this study, we introduce a cardiovascular disease (CVD) policy model which can be used to model remaining life expectancy including a measure of socioecon...

Descripción completa

Detalles Bibliográficos
Autores principales: Lewsey, J D, Lawson, K D, Ford, I, Fox, K A A, Ritchie, L D, Tunstall-Pedoe, H, Watt, G C M, Woodward, M, Kent, S, Neilson, M, Briggs, A H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316925/
https://www.ncbi.nlm.nih.gov/pubmed/25324535
http://dx.doi.org/10.1136/heartjnl-2014-305637
_version_ 1782355641559416832
author Lewsey, J D
Lawson, K D
Ford, I
Fox, K A A
Ritchie, L D
Tunstall-Pedoe, H
Watt, G C M
Woodward, M
Kent, S
Neilson, M
Briggs, A H
author_facet Lewsey, J D
Lawson, K D
Ford, I
Fox, K A A
Ritchie, L D
Tunstall-Pedoe, H
Watt, G C M
Woodward, M
Kent, S
Neilson, M
Briggs, A H
author_sort Lewsey, J D
collection PubMed
description OBJECTIVES: A policy model is a model that can evaluate the effectiveness and cost-effectiveness of interventions and inform policy decisions. In this study, we introduce a cardiovascular disease (CVD) policy model which can be used to model remaining life expectancy including a measure of socioeconomic deprivation as an independent risk factor for CVD. DESIGN: A state transition model was developed using the Scottish Heart Health Extended Cohort (SHHEC) linked to Scottish morbidity and death records. Individuals start in a CVD-free state and can transit to three CVD event states plus a non-CVD death state. Individuals who have a non-fatal first event are then followed up until death. Taking a competing risk approach, the cause-specific hazards of a first event are modelled using parametric survival analysis. Survival following a first non-fatal event is also modelled parametrically. We assessed discrimination, validation and calibration of our model. RESULTS: Our model achieved a good level of discrimination in each component (c-statistics for men (women)—non-fatal coronary heart disease (CHD): 0.70 (0.74), non-fatal cerebrovascular disease (CBVD): 0.73 (0.76), fatal CVD: 0.77 (0.80), fatal non-CVD: 0.74 (0.72), survival after non-fatal CHD: 0.68 (0.67) and survival after non-fatal CBVD: 0.65 (0.66)). In general, our model predictions were comparable with observed event rates for a Scottish randomised statin trial population which has an overlapping follow-up period with SHHEC. After applying a calibration factor, our predictions of life expectancy closely match those published in recent national life tables. CONCLUSIONS: Our model can be used to estimate the impact of primary prevention interventions on life expectancy and can assess the impact of interventions on inequalities.
format Online
Article
Text
id pubmed-4316925
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-43169252015-02-11 A cardiovascular disease policy model that predicts life expectancy taking into account socioeconomic deprivation Lewsey, J D Lawson, K D Ford, I Fox, K A A Ritchie, L D Tunstall-Pedoe, H Watt, G C M Woodward, M Kent, S Neilson, M Briggs, A H Heart Healthcare Delivery, Economics and Global Health OBJECTIVES: A policy model is a model that can evaluate the effectiveness and cost-effectiveness of interventions and inform policy decisions. In this study, we introduce a cardiovascular disease (CVD) policy model which can be used to model remaining life expectancy including a measure of socioeconomic deprivation as an independent risk factor for CVD. DESIGN: A state transition model was developed using the Scottish Heart Health Extended Cohort (SHHEC) linked to Scottish morbidity and death records. Individuals start in a CVD-free state and can transit to three CVD event states plus a non-CVD death state. Individuals who have a non-fatal first event are then followed up until death. Taking a competing risk approach, the cause-specific hazards of a first event are modelled using parametric survival analysis. Survival following a first non-fatal event is also modelled parametrically. We assessed discrimination, validation and calibration of our model. RESULTS: Our model achieved a good level of discrimination in each component (c-statistics for men (women)—non-fatal coronary heart disease (CHD): 0.70 (0.74), non-fatal cerebrovascular disease (CBVD): 0.73 (0.76), fatal CVD: 0.77 (0.80), fatal non-CVD: 0.74 (0.72), survival after non-fatal CHD: 0.68 (0.67) and survival after non-fatal CBVD: 0.65 (0.66)). In general, our model predictions were comparable with observed event rates for a Scottish randomised statin trial population which has an overlapping follow-up period with SHHEC. After applying a calibration factor, our predictions of life expectancy closely match those published in recent national life tables. CONCLUSIONS: Our model can be used to estimate the impact of primary prevention interventions on life expectancy and can assess the impact of interventions on inequalities. BMJ Publishing Group 2015-02-01 2014-10-16 /pmc/articles/PMC4316925/ /pubmed/25324535 http://dx.doi.org/10.1136/heartjnl-2014-305637 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Healthcare Delivery, Economics and Global Health
Lewsey, J D
Lawson, K D
Ford, I
Fox, K A A
Ritchie, L D
Tunstall-Pedoe, H
Watt, G C M
Woodward, M
Kent, S
Neilson, M
Briggs, A H
A cardiovascular disease policy model that predicts life expectancy taking into account socioeconomic deprivation
title A cardiovascular disease policy model that predicts life expectancy taking into account socioeconomic deprivation
title_full A cardiovascular disease policy model that predicts life expectancy taking into account socioeconomic deprivation
title_fullStr A cardiovascular disease policy model that predicts life expectancy taking into account socioeconomic deprivation
title_full_unstemmed A cardiovascular disease policy model that predicts life expectancy taking into account socioeconomic deprivation
title_short A cardiovascular disease policy model that predicts life expectancy taking into account socioeconomic deprivation
title_sort cardiovascular disease policy model that predicts life expectancy taking into account socioeconomic deprivation
topic Healthcare Delivery, Economics and Global Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316925/
https://www.ncbi.nlm.nih.gov/pubmed/25324535
http://dx.doi.org/10.1136/heartjnl-2014-305637
work_keys_str_mv AT lewseyjd acardiovasculardiseasepolicymodelthatpredictslifeexpectancytakingintoaccountsocioeconomicdeprivation
AT lawsonkd acardiovasculardiseasepolicymodelthatpredictslifeexpectancytakingintoaccountsocioeconomicdeprivation
AT fordi acardiovasculardiseasepolicymodelthatpredictslifeexpectancytakingintoaccountsocioeconomicdeprivation
AT foxkaa acardiovasculardiseasepolicymodelthatpredictslifeexpectancytakingintoaccountsocioeconomicdeprivation
AT ritchield acardiovasculardiseasepolicymodelthatpredictslifeexpectancytakingintoaccountsocioeconomicdeprivation
AT tunstallpedoeh acardiovasculardiseasepolicymodelthatpredictslifeexpectancytakingintoaccountsocioeconomicdeprivation
AT wattgcm acardiovasculardiseasepolicymodelthatpredictslifeexpectancytakingintoaccountsocioeconomicdeprivation
AT woodwardm acardiovasculardiseasepolicymodelthatpredictslifeexpectancytakingintoaccountsocioeconomicdeprivation
AT kents acardiovasculardiseasepolicymodelthatpredictslifeexpectancytakingintoaccountsocioeconomicdeprivation
AT neilsonm acardiovasculardiseasepolicymodelthatpredictslifeexpectancytakingintoaccountsocioeconomicdeprivation
AT briggsah acardiovasculardiseasepolicymodelthatpredictslifeexpectancytakingintoaccountsocioeconomicdeprivation
AT lewseyjd cardiovasculardiseasepolicymodelthatpredictslifeexpectancytakingintoaccountsocioeconomicdeprivation
AT lawsonkd cardiovasculardiseasepolicymodelthatpredictslifeexpectancytakingintoaccountsocioeconomicdeprivation
AT fordi cardiovasculardiseasepolicymodelthatpredictslifeexpectancytakingintoaccountsocioeconomicdeprivation
AT foxkaa cardiovasculardiseasepolicymodelthatpredictslifeexpectancytakingintoaccountsocioeconomicdeprivation
AT ritchield cardiovasculardiseasepolicymodelthatpredictslifeexpectancytakingintoaccountsocioeconomicdeprivation
AT tunstallpedoeh cardiovasculardiseasepolicymodelthatpredictslifeexpectancytakingintoaccountsocioeconomicdeprivation
AT wattgcm cardiovasculardiseasepolicymodelthatpredictslifeexpectancytakingintoaccountsocioeconomicdeprivation
AT woodwardm cardiovasculardiseasepolicymodelthatpredictslifeexpectancytakingintoaccountsocioeconomicdeprivation
AT kents cardiovasculardiseasepolicymodelthatpredictslifeexpectancytakingintoaccountsocioeconomicdeprivation
AT neilsonm cardiovasculardiseasepolicymodelthatpredictslifeexpectancytakingintoaccountsocioeconomicdeprivation
AT briggsah cardiovasculardiseasepolicymodelthatpredictslifeexpectancytakingintoaccountsocioeconomicdeprivation